sur NFL BIOSCIENCES (EPA:ALNFL)
NFL Biosciences General Meeting Results
On May 21, 2025, NFL Biosciences held its combined general meeting in Montpellier. Under the chairmanship of Bruno Lafont, all resolutions proposed by the Board of Directors, with the exception of the 14th resolution on company savings plans, were adopted. The meeting was attended by 27 shareholders, representing 37.13% of the voting shares and 44.68% of the voting rights.
NFL Biosciences, listed on Euronext Growth Paris, focuses on the development of botanical drugs to combat addiction. The detailed report of the meeting is available on their website. This meeting marks a milestone in the company's strategic advancement in the biopharmaceutical market.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de NFL BIOSCIENCES